VEGF-A inhibitor monoclonal antibody fragment

This page covers all VEGF-A inhibitor monoclonal antibody fragment drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting VEGF-A (Vascular Endothelial Growth Factor A).

Targets

VEGF-A (Vascular Endothelial Growth Factor A)

Marketed (1)

• ranibizumab PRN · Seoul National University Hospital · Ophthalmology
  Ranibizumab is a monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A (VEGF-A), reducing abnormal blood vessel growth and vascular permeability in the eye.

Patent intelligence

• vegf a inhibitor monoclonal antibody fragment patent landscape — aggregated cliff calendar, attackable patents, originator estates